Artificial Intelligence That Changes Clinical Neurology Practice: Translating Algorithms Into Actionable Care

Topic: Risk, prevention and care in population studies

Artificial intelligence (AI) has stimulated extensive research in clinical neurology, but relatively few AI systems have meaningfully changed bedside decision-making. This translational gap is not explained solely by inadequate algorithms. More often, AI models in neurology remain outside routine practice because they are trained on unstable labels, validated in narrow or single-center datasets, evaluated primarily by discrimination metrics, disconnected from clinical workflow, and deployed without prospective monitoring, reimbursement frameworks, or accountability. In this review, we propose the NEURAL framework for practice-changing neurological AI: Novel clinical insight, External and prospective validation, Utility over accuracy, Real-time workflow integration, Algorithmic transparency, and Long-term outcome linkage. Using this framework, we examine evidence across acute stroke, epilepsy and electroencephalography (EEG), sleep medicine, neurodegenerative disease, movement disorders, headache, vestibular disorders, neuroimmunology, rehabilitation, and neurocritical care. The most clinically advanced examples come from acute stroke, where imaging-based selection, large-vessel occlusion detection, and automated notification are linked to urgent, pathway-defined interventions. Automated EEG triage, focal cortical dysplasia detection, selected sleep-analysis tools, quantitative biomarker pipelines, and AI-assisted longitudinal monitoring may also become clinically meaningful if tested prospectively in real-world workflows. Many high-performing models for dementia progression, prodromal Parkinson disease, outpatient treatment response, and long-horizon risk prediction remain pre-implementation tools because they do not yet define a validated clinical action. Future neurological AI should therefore be judged less by whether it recognizes complex patterns and more by whether it improves the right decision for the right patient at the right time. A clinically useful AI system must demonstrate not only accuracy, but also actionability, workflow fit, equity, safety, sustainability, and measurable benefit for patients and health systems.

Key findings

• The most clinically advanced examples come from acute stroke, where imaging-based selection, large-vessel occlusion detection, and automated notification are linked to urgent, pathway-defined interventions.
• Automated EEG triage, focal cortical dysplasia detection, selected sleep-analysis tools, quantitative biomarker pipelines, and AI-assisted longitudinal monitoring may also become clinically meaningful if tested prospectively in real-world workflows.
• Many high-performing models for dementia progression, prodromal Parkinson disease, outpatient treatment response, and long-horizon risk prediction remain pre-implementation tools because they do not yet define a validated clinical action.
• Future neurological AI should therefore be judged less by whether it recognizes complex patterns and more by whether it improves the right decision for the right patient at the right time.
• A clinically useful AI system must demonstrate not only accuracy, but also actionability, workflow fit, equity, safety, sustainability, and measurable benefit for patients and health systems.

Why it matters

This review proposes the NEURAL framework for artificial intelligence in neurology and notes that most clinically advanced AI examples come from acute stroke, while many high-performing dementia models have not been tested prospectively in real-world workflows. It concerns translating algorithms into practice and does not report any treatment, cure or prevention of Alzheimer's disease.

Study details

• Study designlongitudinal study
• Evidence strengthModerate

Read the original

• DOI: 10.3988/jcn.2026.0312
• PubMed: 42421400
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{yongcheon2026-42421400,
  author  = {Yongcheon, Kim and Seung-Ah, Choe and Seogsong, Jeong and Ding, Jie and Xinshi, Wang and Hwamin, Lee and Byung-Jo, Kim},
  title   = {{Artificial Intelligence That Changes Clinical Neurology Practice: Translating Algorithms Into Actionable Care}},
  journal = {Journal of clinical neurology (Seoul, Korea)},
  year    = {2026},
  doi     = {10.3988/jcn.2026.0312},
  pmid    = {42421400},
  url     = {https://doi.org/10.3988/jcn.2026.0312}
}

Related studies in Health systems and care delivery

• Artificial Intelligence in Medicare and Medicaid: A Review of Clinical Decision Support, Fraud Detection, Prior Authorization, and Healthcare Utilization Not indexed · 2026 · usefulness score 15/100
• Analgesic prescribing in care home residents: how epidemiological studies may inform clinical practice Pain management · 2016-07-07 · usefulness score 38/100
• Performance of Claims-based Alzheimer’s Disease and Related Dementias Algorithms in Medicare Advantage and Fee-for-Service Populations The Journals of Gerontology Series A · 2026-09-17 · usefulness score 52/100
• Performance of Claims-based Dementia Algorithms in Medicare Fee-for-service and Medicare Advantage Populations Innovation in Aging · 2025-12-01 · usefulness score 40/100
• The Forgotten Psychopathology of Depressed Long-Term Care Facility Residents: A Call for Evidence-Based Practice Dementia and geriatric cognitive disorders extra · 2021-02-18 · usefulness score 41/100
• Graphic designed bedroom doors to support dementia wandering in residential care homes: Innovative practice Dementia (London, England) · 2019-08-07 · usefulness score 41/100

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

• Molecular imaging of microglial activation in amyotrophic lateral sclerosis PloS one · 2012-12-31 · usefulness score 47/100 · Inflammation and the immune system
• The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease NeuroImage · 2000-03-01 · usefulness score 44/100 · Brain scans and imaging
• Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study The Lancet. Neurology · 2012-06-28 · usefulness score 60/100 · Getting a diagnosis

Similar studies

• Artificial intelligence as an emerging technology in the current care of neurological disorders 2021 · Digital health tools
• Artificial intelligence in neurodegenerative diseases research: a bibliometric analysis since 2000 2025 · Digital health tools
• Use of artificial intelligence in neurological disorders diagnosis: A scientometric study 2025 · Digital health tools
• Diagnosis, Treatment and Future Perspectives in Artificial Intelligence and Neuronal Diseases 2025 · Digital health tools
• Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review 2023 · Digital health tools
• Leveraging Artificial Intelligence in the Diagnosis of Neurodegenerative Disorders (Alzheimer's and Dementia) and in Managing Medication Schedules" 2025 · Digital health tools

More on Health systems and care delivery

• A review that covers this ground Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis Age and ageing · 2017-07-01 · usefulness score 86/100
• Newest in this subject Family physicians' attitudes toward people with dementia and their association with empathy Research Square · 2026-10-14 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type Journal of the American College of Radiology : JACR · 2026-09-15 · Peer-reviewed · usefulness score 43/100

See all studies in Health systems and care delivery →